Oramed Pharmaceuticals (ORMP) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.18
-0.11
-0.03
0.04

Details

Expected EPS
0.04
Actual EPS
0.04
Surprise EPS
0
Surprise Percent
+0%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of 0.04 per share for Q2 2024.

0 Comments

Share your thoughts